WO2021060652A1 - Souche st-8 de staphylococcus haemolyticus et son utilisation pour améliorer l'état de la peau - Google Patents

Souche st-8 de staphylococcus haemolyticus et son utilisation pour améliorer l'état de la peau Download PDF

Info

Publication number
WO2021060652A1
WO2021060652A1 PCT/KR2020/006996 KR2020006996W WO2021060652A1 WO 2021060652 A1 WO2021060652 A1 WO 2021060652A1 KR 2020006996 W KR2020006996 W KR 2020006996W WO 2021060652 A1 WO2021060652 A1 WO 2021060652A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
strain
staphylococcus
culture solution
composition
Prior art date
Application number
PCT/KR2020/006996
Other languages
English (en)
Korean (ko)
Inventor
이동걸
김민지
김미선
강승현
박명삼
Original Assignee
코스맥스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코스맥스 주식회사 filed Critical 코스맥스 주식회사
Publication of WO2021060652A1 publication Critical patent/WO2021060652A1/fr

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44—Staphylococcus

Definitions

  • Another aspect is to provide a lysate of the strain, a culture medium, or an extract of the culture medium.
  • the Staphylococcus haemolyticus ST-8 strain may be a strain containing 16s rRNA of SEQ ID NO: 1.
  • Another aspect also provides a method of preventing, ameliorating, or treating a condition in an individual comprising the step of treating or administering to an individual in need thereof an effective amount of the above composition.
  • a real-time PCR machine (Step One Plus, Applied Biosystems, USA) by adding cybergreen (SYBR Green supermix, Applied Biosystems, USA) together with primers and cDNA to the target gene COL1A1 using the synthesized cDNA as a template.
  • Real-time polymerase chain reaction was performed at.
  • the expression level of the gene was finally analyzed through correction for the ⁇ -actin gene, and the results are shown in FIG. 1.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne un nouveau micro-organisme, un lysat de celui-ci, une solution de culture, un extrait d'une solution de culture, et une utilisation de celui-ci pour améliorer l'état de la peau.
PCT/KR2020/006996 2019-09-27 2020-05-29 Souche st-8 de staphylococcus haemolyticus et son utilisation pour améliorer l'état de la peau WO2021060652A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2019-0119750 2019-09-27
KR1020190119750A KR102199063B1 (ko) 2019-09-27 2019-09-27 스타필로코커스 헤모리티쿠스 st-8 균주 및 그의 피부 상태 개선 용도

Publications (1)

Publication Number Publication Date
WO2021060652A1 true WO2021060652A1 (fr) 2021-04-01

Family

ID=74127962

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2020/006996 WO2021060652A1 (fr) 2019-09-27 2020-05-29 Souche st-8 de staphylococcus haemolyticus et son utilisation pour améliorer l'état de la peau

Country Status (2)

Country Link
KR (1) KR102199063B1 (fr)
WO (1) WO2021060652A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102286080B1 (ko) * 2020-05-08 2021-08-05 코스맥스 주식회사 로티아 크리스티내 균주 및 그의 피부 상태 개선 용도

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02290803A (ja) * 1989-05-01 1990-11-30 Yakult Honsha Co Ltd 抗菌性組成物およびその用途
EP2361632A1 (fr) * 2010-02-19 2011-08-31 Protectimmun GmbH Bactérie environnementale spécifique pour la protection contre le traitement des maladies allergiques, inflammatoires chroniques et/ou auto-immunes
KR20170003478A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 피부 개선용 균주 및 이를 포함하는 피부 개선용 키트
US20180250222A1 (en) * 2017-02-27 2018-09-06 Continuum Group Llc Sunscreen
KR20190010054A (ko) * 2017-07-20 2019-01-30 대한민국(농촌진흥청장) 항균 활성을 갖는 스타필로코커스 갈리나럼 균주 및 이의 항균 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3010905A1 (fr) * 2013-09-25 2015-03-27 Oreal Inhibiteurs de staphylococcus haemolyticus pour la prevention et/ou le traitement de la dermatite atopique
KR102123022B1 (ko) 2018-12-31 2020-06-16 코스맥스 주식회사 피부에 효능이 있는 고농도 프로바이오틱스를 포함하는 조성물

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02290803A (ja) * 1989-05-01 1990-11-30 Yakult Honsha Co Ltd 抗菌性組成物およびその用途
EP2361632A1 (fr) * 2010-02-19 2011-08-31 Protectimmun GmbH Bactérie environnementale spécifique pour la protection contre le traitement des maladies allergiques, inflammatoires chroniques et/ou auto-immunes
KR20170003478A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 피부 개선용 균주 및 이를 포함하는 피부 개선용 키트
US20180250222A1 (en) * 2017-02-27 2018-09-06 Continuum Group Llc Sunscreen
KR20190010054A (ko) * 2017-07-20 2019-01-30 대한민국(농촌진흥청장) 항균 활성을 갖는 스타필로코커스 갈리나럼 균주 및 이의 항균 용도

Also Published As

Publication number Publication date
KR102199063B1 (ko) 2021-01-06

Similar Documents

Publication Publication Date Title
KR102197174B1 (ko) 큐티박테리움 그래뉼로섬 균주 및 그의 피부 상태 개선 용도
WO2021060659A1 (fr) Souche st-1 de staphylococcus capitis, et son utilisation pour améliorer l'état de la peau
WO2021060656A1 (fr) Souche de staphylococcus gallinarum st-4 et son utilisation pour améliorer l'état de la peau
WO2021060654A1 (fr) Souche de staphylococcus epidermidis st-6 et son utilisation pour améliorer l'état de la peau
WO2021060652A1 (fr) Souche st-8 de staphylococcus haemolyticus et son utilisation pour améliorer l'état de la peau
WO2021060658A1 (fr) Souche de staphylococcus lentus st-2 et son utilisation pour l'amélioration de l'état de la peau
WO2021060648A1 (fr) Souche st-12 de staphylococcus warneri et son utilisation pour améliorer l'état de la peau
WO2022145960A9 (fr) Souche de weissella cibaria et son utilisation
KR102334455B1 (ko) 코리네박테리움 맥진레이 균주 및 그의 피부 상태 개선 용도
WO2021060653A1 (fr) Souche de staphylococcus sciuri st-7 et son utilisation pour améliorer l'état de la peau
WO2021060655A1 (fr) Souche de staphylococcus saprophyticus st-5 et son utilisation pour améliorer l'état de la peau
WO2021060650A1 (fr) Souche de staphylococcus xylosus st-10, et son utilisation pour améliorer l'état de la peau
WO2021060647A1 (fr) Souche de staphylococcus schleiferi st-13 et son utilisation pour améliorer l'état de la peau
WO2021060651A1 (fr) Souche de staphylococcus simulans st-9, et son utilisation pour améliorer l'état de la peau
WO2021060649A1 (fr) Souche de staphylococcus intermedius st-11 et son utilisation pour améliorer l'état de la peau
WO2021060657A1 (fr) Souche de staphylococcus cohnii st-3 et son utilisation pour améliorer l'état de la peau
WO2023018078A1 (fr) Souche de micrococcus antarcticus et son utilisation pour améliorer l'état de la peau
WO2023018077A1 (fr) Souche de microccocus cohnii et son utilisation pour améliorer l'état de la peau
WO2023243924A1 (fr) Souche de micrococcus terreus et son utilisation pour améliorer l'état de la peau
WO2023038404A1 (fr) Bifidobacterium animalis subsp. lactis et son utilisation pour améliorer l'état de la peau
WO2024005443A1 (fr) Souche de micrococcus flavus et son utilisation pour améliorer l'état de la peau
KR102691627B1 (ko) 로제오모나스 뮤코사 균주 및 그의 피부 상태 개선 용도
WO2024025173A1 (fr) Composition cosmétique comprenant une souche de staphylococcus sp., une souche de streptococcus sp., une souche de cutibacterium sp., une souche d'enhydrobacter sp. et un mélange de fragments d'adn
KR102336747B1 (ko) 판토에아 아나나티스 균주 및 그의 피부 상태 개선 용도
KR102334449B1 (ko) 코리네박테리움 아코렌스 균주 및 그의 피부 상태 개선 용도

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20869581

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20869581

Country of ref document: EP

Kind code of ref document: A1